top of page


US FDA approves Lenacapavir for HIV prevention
According to recent estimates, there are around 2.14 million HIV cases in India. Around 83% of these are in the age group 15-49 years (1). Antiretroviral therapy is the common treatment strategy followed which involves taking a combination of HIV medicines daily, monthly, or every other month. Although there is no cure for HIV, prompt treatment can help HIV patients live a healthy life and reduce the risk of transmission (2). On June 18th, 2025, the USFDA approved Gilead's Y

Ms. Roma Joglekar
Sep 8, 20252 min read
bottom of page